R Fischer

No ORCID on file · 9 papers in corpus
review 2023
Best practice & research. Clinical obstetrics & gynaecology ·doi:10.1016/j.bpobgyn.2023.102350

This non-interventional study compared the effectiveness of recombinant human follicle-stimulating hormone (r-hFSH) and recombinant human luteinizing hormone (r-hLH) (2:1 ratio) versus r-hFSH alone for ovarian stimulation (OS) during assist…

other 2023
Best practice & research. Clinical obstetrics & gynaecology ·doi:10.1016/j.bpobgyn.2023.102395
review 2022
·doi:10.33140/jgrm.06.04.07

Endometriosis is a common problem affecting 5-10% of women of childbearing age. It is a condition with unknown pathology, leaving us with several theories. However, about half of women with endometriosis complain of difficulty conceiving. T…

2022
·doi:10.1093/humrep/deac104.027

Abstract Study question Can an endometriosis-specific protein signature in small extracellular vesicles (sEV) from peritoneal fluid (PF) be utilised as a non-invasive biomarker of the condition? Summary answer Yes, potentially. We found dif…

2019
rct 2015
BMJ open ·doi:10.1136/bmjopen-2015-008297

INTRODUCTION: The results of a recent meta-analysis showed that adding recombinant human luteinising hormone (r-hLH) to recombinant human follicle-stimulating hormone (r-hFSH) for ovarian stimulation was beneficial in poor responders, resul…

observational 1981
Zentralblatt für Gynäkologie

Gonorrhoea was detected in 7.3 per cent of 423 patients with gynaecological inflammations. Positive findings were recorded from 8.5 per cent of 248 patients with adnexitis and 6.9 per cent of 130 patients with fluor. However, gonorrhoea inc…

review 1977
Strahlentherapie

A review of the principles of histological classification of the malignant ovarian tumours is given. In the center of the discussion figure the tumours originating from the surface epithelium, which make up the majority of ovarian tumours. …

other 1963
Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen